Tie1 deficiency induces endothelial-mesenchymal transition

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• Endothelial-mesenchymal transition (EndMT) is crucial for embryonic development and implicated in various pathologies.
• The precise molecular triggers and regulators of EndMT induction are not fully understood.

Purpose of the Study:

• To elucidate the molecular mechanisms regulating EndMT induction.
• To investigate the role of receptor tyrosine kinases Tie1 and Tie2 in EndMT.
• To explore the potential involvement of EndMT in pancreatic tumor development.

Main Methods:

• Utilized human endothelial cells to study EndMT.
• Investigated the effects of suppressing Tie1 and Tie2 receptor tyrosine kinases.
• Analyzed the role of Slug deficiency in reversing EndMT.
• Examined the involvement of Erk1/2, Erk5, and Akt signaling pathways in regulating Slug promoter activity.
• Observed EndMT in human pancreatic tumor samples.

Main Results:

• Suppression of Tie1, but not Tie2, induced EndMT in human endothelial cells.
• Slug deficiency effectively reverted the Tie1 deficiency-induced EndMT.
• Erk1/2, Erk5, and Akt signaling cascades were found to control Slug promoter activity following Tie1 deficiency.
• EndMT was observed in human pancreatic tumors, suggesting a pathological role.

Conclusions:

• Tie1 downregulation is a key inducer of EndMT in human endothelial cells.
• The Tie1-Slug axis plays a critical role in regulating EndMT.
• Signaling pathways including Erk1/2, Erk5, and Akt are involved in mediating Tie1 deficiency-induced EndMT.
• EndMT associated with Tie1 downregulation may contribute to the pathological development of tumor stroma.